|
|
Vetevax
Vetevax is a repository site for veterinary vaccines.
Veterinary vaccines based on licensed pathogen/disease Cancer (Cancer):
- CVB4/p24(73(3))
- Poliovirus vector expressing model antigen H2-Kb-restricted CTL epitope
- Maraba virus MG1 Vaccine
- rMeV- SCD
- rMCMV-TRP2
- ALVAC-P53 Vaccine
- rMVTT- HPV16-E6/E7
- MG1-hDCT Vaccine
- RIPO(H3.3)
- AMHR2-ED
- KLH-id Vaccine
- A2/4-1BBL melanoma vaccine
- adenovirus-transfected autologous DC vaccine plus CIK cells
- Bivalent Vaccine with Adjuvant OPT-821
- Anti-HER2/HER3 Dendritic Cell Vaccine
- Autologous Lymphoma Immunoglobulin-derived scFv-chemokine DNA Vaccine
- B7.1/IL-2 Leukaemia Cell Vaccine
- Autolgous DC Vaccine Pulsed with Autologous Tumor Homogenate for Metastatic RCC
- Autologous dendritic cell vaccine loaded with personalized peptides (PEP-DC vaccine)
- Autologous Cancer Testis Antigen Specific Dendritic Cell Vaccine
- Autologous Neuroblastoma Vaccine
- Autologous Total Tumor mRNA and CMV-pp65-flLAMP mRNA Loaded Liposome Vaccine
- GM.CD40L Cell Vaccine
- Bcl-Xl_42-CAF09b Vaccine
- BC-819
- Bcr-Abl (b3a2)-Derived Peptide Vaccine
- GD2L, GD3L, Globo H, fucosyl GM1, and N-propionylated polysialic acid KLH Conjugate Vaccine
- Cancer Stem Cell DC Vaccine
- CDX-1307 Vaccine
- Chimeric exosomal tumor vaccine
- CLL Idiotypic DNA Vaccine
- MART-1, tyrosinase and MAGE-A6 Autologous DC Vaccine
- Neoantigen-loaded Autologous Dendritic Cell Vaccine
- Dendritic Cell Tumor Peptide Vaccine
- HLA-A1, HLA-A2, and CD40-Ligand Pulsed Dendritic Cell Vaccine
- Multiantigen Liposome Loaded Dendritic Cell Vaccine
- Dendritic vaccine, allogeneic hematopoietic stem cells, cytotoxic lymphocytes
- Dendritic vaccine, autologous hematopoietic stem cells, cytotoxic lymphocytes
- Electrofusion DC vaccine
- Cyclin B1/WT-1/CEF-Loaded DC Vaccine
- ESR1 peptide vaccine
- Follicular lymphoma, patient-specific, soluble protein idiotype vaccine
- FRAME-001 personalized vaccine
- Genetically Engineered Allogeneic Prostate Carinoma Cells Secreting Interleukin-2 and Interferon Gamma
- GM-K562 cell vaccine
- HER-2-neu, CEA peptides, GM-CSF, Montanide ISA-51 vaccine
- H3.3K27M-specific Peptide Vaccine
- Hodgkin's antigens-GM-CSF-expressing cell vaccine
- HyperAcute - Breast cancer vaccine
- HyperAcute-Melanoma Vaccine
- HyperAcute-Prostate Cancer Vaccine
- IL15-DC Vaccine
- DIPG and GMB Immunomodulatory DC Vaccine
- Intracel KLH Vaccine
- KLH and Tumor Lysate Pulsed DC Vaccine
- KLH-pulsed autologous dendritic cell vaccine
- LMP2A-loaded conventional DC vaccine
- MAGE-A1, Her-2/neu, FBP peptides ovarian cancer vaccine
- Mature dendritic cell melanoma vaccine
- gp100 mature dendritic cell vaccine
- MDX-1379 (gp100) Melanoma Peptide Vaccine
- MDX-CTLA4 Antibody/Tyrosinase/gp100/MART-1 Melanoma Vaccine
- melanoma helper peptide vaccine
- IL-2, Peptide, and GM-CSF-in-adjuvant Melanoma Vaccine
- Allogeneic HLA-A2/4-1BB ligand-expressing Melanoma Vaccine
- Mixed bacterial vaccine
- MT-201-GBM monocyte vaccine
- MUC1 Peptide-Poly-ICLC Vaccine
- Multi-epitope HER2 Peptide Vaccine TPIV100
- Multi-epitope melanoma peptide vaccine
- Multipeptide XS15 Vaccine
- Multiple Signals loaded Dendritic Cells Vaccine
- MVA-BN-CV301
- MVF-HER-2(628-647)-CRL 1005 vaccine
- Dendritic Cell/Myeloma Fusion Vaccine
- mRNA-based Personalized Cancer Vaccine NCI-4650
- NEO-PV-01 vaccine
- Neoantigen DNA Vaccine
- Neoantigen Peptide Vaccine
- mRNA neoantigen tumor vaccine
- NY-ESO-1/PRAME/MAGE-A3/WT-1 Peptide Vaccine
- Autologous Oxidized Ovarian Tumor Cell Lysate Vaccine
- OCDC and NeoDC Vaccine
- neoantigen synthetic long peptide vaccine
- Oral Therapeutic Vaccine V3-X
- Autologous, DNP-Modified Ovarian Cancer Vaccine
- P501-AS15 vaccine
- Allogeneic GM-CSF-secreting Lethally Irradiated Pancreatic Tumor Cell Vaccine
- PD-L1/IDO Peptide Vaccine IO102-103
- PD-L1 peptide vaccine
- mRNA tumor antigen DC vaccine
- Personalized mature dendritic cell vaccine
- Pancreatic tumor personalized neoantigen vaccine
- Personalized follicular lymphoma vaccine
- PolyPEPI1018 CRC Vaccine
- Polyvalent melanoma vaccine
- Prodencel
- pUMVC3-IGFBP2-HER2-IGF1R Plasmid DNA Vaccine
- Autologous CMV-pp65-flLAMP mRNA Loaded Dendritic Cell Vaccine
- KRAS-targeted mRNA vaccine
- SCIB1 DNA vaccine
- Sialyl Lewis-keyhole limpet hemocyanin conjugate vaccine
- Dendritic Cell Survivin Vaccine
- HER2 ICD peptide vaccine
- Bcr-Abl (b2a2)-Derived Peptide Vaccine
- Oral Cancer Vaccine V3-OVA
- Tetanus peptide melanoma vaccine
- RAS Peptide Cancer Vaccine TG01
- TGFβ2 Antisense-GMCSF Gene Modified Autologous Tumor Cell Vaccine
- Transgenic Lymphocyte Immunization Vaccine
- TriAd Cancer Vaccine
- Total Tumor RNA-loaded Dendritic Cell Vaccine
- Tumor antigen-sensitized DC vaccine
- P30-linked EphA2/CMV pp65/Survivin Peptide Vaccine P30-EPS
- AGS-003-BLD Vaccine
- Autologous tumor cell lysate vaccine
- Tumor Lysate/KLH Pulsed Dendritic Cell Vaccine
- Tumor Lysate-pulsed Dendritic Cell Vaccine
- NY-ESO-1, MAGE-A1, and MAGE-A3 Dendritic Cell Vaccine
- IDO peptide vaccine
- HPV E6/E7-encoding Semliki Forest Virus Vaccine Vvax001
- 4-peptide melanoma vaccine
- ALVAC gp100 Vaccine
- Bcr-abl peptide vaccine
- TVI-Brain-1
- DC/AML Fusion Vaccine
- Personalized NeoAntigen Melanoma Vaccine
- secPD-L1
- HLA Neoantigen Vaccine
- HPV16 E6/E7 Melanoma Vaccine
- Autologous CLL Tumor Cell Vaccine
- CAR G36-PDL1
- GD2-CAR
- ALK peptide vaccine
- Mutated neopeptide vaccine
- Antigen-CPP vaccine
- GVAX Leukemia Vaccine
- Personal neoantigen cancer vaccine
- Whole tumor cell-based leukemia vaccine
Provenance: All queried data come from the VIOLIN database.
Statistics: Click Here to find updated statistics of the VIOLIN database.
|
